...
首页> 外文期刊>Kidney Research and Clinical Practice >Comparison of glomerular filtration rates calculated by different serum cystatin C-based equations in patients with chronic kidney disease
【24h】

Comparison of glomerular filtration rates calculated by different serum cystatin C-based equations in patients with chronic kidney disease

机译:慢性肾脏病患者不同血清半胱氨酸蛋白酶抑制剂C方程计算肾小球滤过率的比较

获取原文
           

摘要

Background: We aimed to evaluate the performance of serum cystatin C-based equations in calculating the glomerular filtration rate (GFR) in patients with varying stages of chronic kidney disease (CKD). Methods: Serum cystatin C and creatinine levels were measured in 615 CKD patients. The CKD stage was determined by the creatinine-based estimated GFR (eGFR) equation using the four-variable abbreviated Modification of Diet in Renal Disease equation suggested by the Kidney Disease Outcome Quality Initiative with the addition of a coefficient applicable to Korean populations (K-aMDRD). In each CKD stage, the ratio of serum cystatin C to creatinine was calculated and six different cystatin C-based equations were used to estimate GFR. Cystatin C-based eGFR and aMDRD eGFR values were compared using the paired t test, Pearson correlation test, and the Bland-Altman plot. Results: The mean age of patients was 53.21+/-14.45 years; of the 615 patients, 346 were male. The serum cystatin C-to-creatinine ratio was inversely correlated with the CKD stage. Compared with the K-aMDRD values, the results of the Hoek, Filler, and Le Bricon's cystatin C-based eGFR equations were lower in CKD Stages 1-3 and higher in Stages 4 and 5. However, the results of the Orebro-cystatin (Gentian) equation [GFR=100/ScytC (mL/minute/1.73m^2) - 14] were similar to those of the K-aMDRD equation in CKD Stages 4 and 5 (15.44+/-9.45 vs. 15.17+/-9.05mL/minute/1.73m^2, respectively; P=0.722; bias=0.27+/-8.87). Conclusion: The eGFRs obtained from the six cystatin C-based equations differed widely. Therefore, further studies are required to determine the most accurate equation to estimate GFR in Koreans with CKD.
机译:背景:我们旨在评估基于血清胱抑素C的方程式在计算不同阶段的慢性肾脏病(CKD)患者的肾小球滤过率(GFR)中的性能。方法:测定615例CKD患者的血清胱抑素C和肌酐水平。 CKD阶段由基于肌酐的估计GFR(eGFR)方程确定,使用肾脏疾病结果质量计划建议的四变量缩写“饮食中的肾脏疾病饮食修正”方程,并增加适用于韩国人群的系数(K- aMDRD)。在每个CKD阶段,计算血清胱抑素C与肌酐的比率,并使用六个基于胱抑素C的方程式估算GFR。使用配对t检验,Pearson相关检验和Bland-Altman图,比较基于胱抑素C的eGFR和aMDRD eGFR值。结果:患者的平均年龄为53.21 +/- 14.45岁;在615位患者中,有346位是男性。血清胱抑素C与肌酐之比与CKD阶段呈负相关。与K-aMDRD值相比,Hoek,Filler和Le Bricon基于胱抑素C的eGFR方程的结果在CKD 1-3阶段较低,而在4和5阶段较高。但是,Orebro-cystatin的结果(Gentian)方程[GFR = 100 / ScytC(mL / min / 1.73m ^ 2)-14]与CKD第4阶段和第5阶段的K-aMDRD方程相似(15.44 +/- 9.45对15.17 + / -9.05mL /分钟/1.73m^2;P=0.722;偏差= 0.27 +/- 8.87)。结论:从六个基于胱抑素C的方程式获得的eGFR差异很大。因此,需要进一步的研究来确定最准确的方程,以估计患有CKD的韩国人的GFR。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号